Literature DB >> 8889412

The effects of a cold-water immersion stressor on the reinforcing and subjective effects of fentanyl in healthy volunteers.

J P Zacny1, M A McKay, A Y Toledano, S Marks, C J Young, P A Klock, J L Apfelbaum.   

Abstract

The reinforcing and subjective effects of fentanyl, an opioid analgesic, were tested in ten healthy volunteers without histories of drug abuse, as a function of the temperature of a water bath in which the volunteers' forearms were immersed. The temperatures were body-temperature (37 degrees C), moderately cold (10 degrees C), and very cold (2 degrees C). A discrete-trial choice procedure was used in which, in each session, volunteers sampled 50 micrograms of fentanyl (delivered as a bolus via an infusion pump) and saline, and then on three successive trials, chose between the two. Volunteers then had to immerse their non-dominant forearm in the water bath 5 min after a drug delivery. Fentanyl was chosen on 77% of choice occasions in the 10 degrees C and 2 degrees C water conditions, which was significantly different from chance levels, and on 60% of choice occasions in the 37 degrees C water condition, which did not differ from chance levels. Several subjective effects of fentanyl were also modulated by the temperature of the water bath. We conclude that in the context of a painful stimulus, 50 micrograms of fentanyl functions as a reinforcer in non-drug abusers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889412     DOI: 10.1016/0376-8716(96)01274-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  20 in total

1.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

Review 2.  Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Authors:  Daniel P Alford; Peggy Compton; Jeffrey H Samet
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

3.  Opioid treatment of experimental pain activates nuclear factor-κB.

Authors:  Peggy Compton; Charles Griffis; Elizabeth Crabb Breen; Matthew Torrington; Ryan Sadakane; Eshetu Tefera; Michael R Irwin
Journal:  J Opioid Manag       Date:  2015 Mar-Apr

4.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

5.  Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.

Authors:  Gillian A Beauchamp; Erin L Winstanley; Shawn A Ryan; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

6.  Sex-dependent effects of cannabis-induced analgesia.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Drug Alcohol Depend       Date:  2016-08-05       Impact factor: 4.492

7.  Effects of stress on responses to methamphetamine in humans.

Authors:  Anna Söderpalm; Lilia Nikolayev; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 8.  Management of opioid medications in patients with chronic pain and risk of substance misuse.

Authors:  Seddon R Savage
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

9.  The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.

Authors:  David Andrew Tompkins; Michael T Smith; George E Bigelow; Ruin Moaddel; Swarajya Lakshmi Vatem Venkata; Eric C Strain
Journal:  Clin J Pain       Date:  2014-01       Impact factor: 3.442

10.  Challenges in using opioids to treat pain in persons with substance use disorders.

Authors:  Seddon R Savage; Kenneth L Kirsh; Steven D Passik
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.